Company Analysis

Dyadic International, Inc. (DYAI)

Nasdaq: DYAI · Biological Products, (No Diagnostic Substances) · Jupiter, FL · filing with the SEC since 2003
Grade4.2
◀ Past 5.2● Present 4.6▶ Future 3.3
1 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

4 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Dyadic International, Inc.’s names, not what it holds today.

Patents granted
4
4 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against none in 2024 and 1 in 2023
Applications published
11
since 2001, to Dec 31, 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'03'08'09'12'13'14'15'17'20'23
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
DYADIC INTERNATIONAL INC. its own name
US, as the owner printed on each patent
4 granted
10 published
DYADIC INTERNATIONAL, INC. its own name
named as the applicant on its applications, in US
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Aug 29, 202311,738,080Production of flu vaccine in Myceliophthora thermophilaBiotechnologyDYADIC INTERNATIONAL INC.
Oct 8, 20138,551,751BX11 enzymes having xylosidase activityBiotechnologyDYADIC INTERNATIONAL INC.
Nov 6, 20128,304,212Methods and compositions for degradation of lignocellulosic materialBiotechnologyDYADIC INTERNATIONAL INC.
Jun 3, 20036,573,086Transformation system in the field of filamentous fungal hostsBiotechnologyDYADIC INTERNATIONAL INC.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 2, 20232023/0346913PRODUCTION OF FLU VACCINE IN MYCELIOPHTHORA THERMOPHILABiotechnologyDYADIC INTERNATIONAL INC.
Jul 9, 20202020/0215183PRODUCTION OF FLU VACCINE IN MYCELIOPHTHORA THERMOPHILABiotechnologyDYADIC INTERNATIONAL, INC. · patent 11,738,080 granted from it
Feb 9, 20172017/0037417EXPRESSION AND HIGH-THROUGHPUT SCREENING OF COMPLEX EXPRESSED DNA LIBRARIES IN FILAMENTOUS FUNGIBiotechnologyDYADIC INTERNATIONAL INC. · patent 9,862,956 granted from it
Jul 30, 20152015/0211013EXPRESSION AND HIGH-THROUGHPUT SCREENING OF COMPLEX EXPRESSED DNA LIBRARIES IN FILAMENTOUS FUNGIBiotechnologyDYADIC INTERNATIONAL INC. · patent 9,862,956 granted from it
Nov 6, 20142014/0329292NOVEL FUNGAL ENZYMESBiotechnologyDYADIC INTERNATIONAL INC.
May 8, 20142014/0127754METHODS AND COMPOSITIONS FOR DEGRADATION OF LIGNOCELLULOSIC MATERIALBiotechnologyDYADIC INTERNATIONAL INC.
Feb 9, 20122012/0036599NOVEL FUNGAL ENZYMESBiotechnologyDYADIC INTERNATIONAL INC.
Feb 2, 20122012/0030839Expression and High-Throughput Screening of Complex Expressed DNA Libraries in Filamentous FungiBiotechnologyDYADIC INTERNATIONAL INC. · patent 8,680,252 granted from it
Feb 2, 20122012/0030838NOVEL FUNGAL ENZYMESBiotechnologyDYADIC INTERNATIONAL INC.
Nov 12, 20092009/0280105Novel Fungal EnzymesBiotechnologyDYADIC INTERNATIONAL INC. · patent 7,923,236 granted from it

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton DYAI · research, not advice